Market Tracker

10/21 6:05pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

5.15
Data as of 3:59pm ET
 -0.16 / -3.01%
Today’s Change
3.81
Today|||52-Week Range
7.90
-15.16%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close5.31
Today’s open5.31
Day’s range4.94 - 5.31
Volume92,063
Average volume (3 months)93,104
Market cap$188.0M
Dividend yield--
Data as of 3:59pm ET, 10/21/2014

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CARACara Therapeutics In...-0.16-1.95%
IDRAIdera Pharmaceutical...+0.08+3.48%
OHRPOHR Pharmaceutical I...+0.03+0.41%
ZGNXZogenix Inc-0.06-4.35%
Data as of 3:59pm ET, 10/21/2014

Financials

Next reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts